Proscia nabs $8.3 mln Series A

Philadelphia-based Proscia, a digital pathology platform for cancer diagnosis, has raised $8.3 million in Series A funding. Flybridge Capital Partners led the round with participation from other backers that included Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures and RobinHood Ventures.

ManagersNorth AmericaUSHealthcareBriefs